Literature DB >> 7161627

Alzheimer's disease. Correlation of cortical choline acetyltransferase activity with the severity of dementia and histological abnormalities.

G K Wilcock, M M Esiri, D M Bowen, C C Smith.   

Abstract

We have examined the choline acetyltransferase [CAT] activity in autopsy samples of frontal and temporal lobe cortex from 47 patients (31 with Alzheimer's disease, 4 with dementia due to cerebrovascular disease and 12 undemented controls) and compared it with the severity of dementia during life and with the numbers of argyrophilic plaques and neurofibrillary tangles in the corresponding areas of cortex in the contralateral cerebral hemisphere. CAT activity was significantly reduced, most severely in the temporal lobe, in patients with Alzheimer's disease but not in patients with a cerebrovascular cause for their dementia, and CAT activity showed no significant reduction with age in the undemented control patients. In the patients with Alzheimer's disease the reduction in CAT activity was significantly correlated with the severity of dementia and with the numbers of neurofibrillary tangles, but not argyrophilic plaques, present in the corresponding contralateral cortex.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7161627     DOI: 10.1016/0022-510x(82)90045-4

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  95 in total

1.  beta -Amyloid peptide blocks the response of alpha 7-containing nicotinic receptors on hippocampal neurons.

Authors:  Q Liu ; H Kawai; D K Berg
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

2.  Rac1b increases with progressive tau pathology within cholinergic nucleus basalis neurons in Alzheimer's disease.

Authors:  Sylvia E Perez; Damianka P Getova; Bin He; Scott E Counts; Changiz Geula; Laurent Desire; Severine Coutadeur; Helene Peillon; Stephen D Ginsberg; Elliott J Mufson
Journal:  Am J Pathol       Date:  2011-12-03       Impact factor: 4.307

3.  Cholinergic nicotinic systems in Alzheimer's disease: prospects for pharmacological intervention.

Authors:  Robyn Vesey; Jennifer M Birrell; Clare Bolton; Ruth S Chipperfield; Andrew D Blackwell; Tom R Dening; Barbara J Sahakian
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

4.  Sequence variation in the CHAT locus shows no association with late-onset Alzheimer's disease.

Authors:  Denise Harold; Timothy Peirce; Valentina Moskvina; Amanda Myers; Susan Jones; Paul Hollingworth; Pamela Moore; Simon Lovestone; John Powell; Catherine Foy; Nicola Archer; Sarah Walter; Amanda Edmonson; Stephen McIlroy; David Craig; Peter A Passmore; Alison Goate; John Hardy; Michael O'Donovan; Julie Williams; Malcolm Liddell; Michael J Owen; Lesley Jones
Journal:  Hum Genet       Date:  2003-05-21       Impact factor: 4.132

Review 5.  Expression profile analysis of neurodegenerative disease: advances in specificity and resolution.

Authors:  Jason G Glanzer; Phillip G Haydon; James H Eberwine
Journal:  Neurochem Res       Date:  2004-06       Impact factor: 3.996

6.  A double-blind, placebo controlled trial of high-dose lecithin in Alzheimer's disease.

Authors:  A Little; R Levy; P Chuaqui-Kidd; D Hand
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-08       Impact factor: 10.154

7.  Immunoglobulin and other proteins in the cerebrospinal fluid of patients with Alzheimer's disease.

Authors:  H M Chapel; M M Esiri; G K Wilcock
Journal:  J Clin Pathol       Date:  1984-06       Impact factor: 3.411

8.  Laminar distribution of neocortical senile plaques in senile dementia of the Alzheimer type.

Authors:  C Duyckaerts; J J Hauw; F Bastenaire; F Piette; C Poulain; V Rainsard; F Javoy-Agid; P Berthaux
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

9.  Evidence for an increased rate of choline efflux across erythrocyte membranes in Alzheimer's disease.

Authors:  D A Butterfield; M M Nicholas; W R Markesbery
Journal:  Neurochem Res       Date:  1985-07       Impact factor: 3.996

10.  MRI-based volumetric measurement of the substantia innominata in amnestic MCI and mild AD.

Authors:  S George; E J Mufson; S Leurgans; R C Shah; C Ferrari; L deToledo-Morrell
Journal:  Neurobiol Aging       Date:  2009-12-14       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.